Is Adjuvant Therapy Necessary for Stage IB Gastric Cancer: A Retrospective Cohort Study
Because adjuvant therapy did not demonstrate any benefits in terms of tumor recurrence or DFS, these treatment strategies may be unnecessary for IB GC patients after gastrectomy. Further studies are required to identify subgroups of IB GC patients who may benefit from adjuvant treatments.
Authors
- Mingyu Gu (ORCID: https://orcid.org/0009-0006-9085-8749)
- Xinxin Wang (ORCID: https://orcid.org/0009-0006-2084-4392)
- Minghai Wen
- Binghe Zhao
- C Sui
Institutions
- Chinese PLA General Hospital (CN)
Publication Details
- Journal
- Annals of Surgical Oncology
- Published
- 2024-11-07
- DOI
- https://doi.org/10.1245/s10434-024-16444-w
- Citations
- 2
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.84
Funders
- Beijing Municipal Science and Technology Commission